Diagnostics & prognostics

Diagnosis and prognosis of brain injury can be complex – but is simple blood test on the horizon?

False discoveries have plagued biomarker research for years: don't trust everything you read.

Do we finally have an effective blood biomarker for studying progression of Huntington’s disease?

A unique type of B cell appears to play a role in the development of autoimmune disorders.

Could chiral amino acids function as biomarkers for kidney disease?

Could an existing blood test improve treatment choices – and outcomes – for some colon cancer patients?

Why are so many patients with HIV still dying too young?

A 30-year-old medical puzzle leads researchers to develop a new molecular therapy.

Circulating tumor DNA profiling can yield new insights into early-stage lung cancer evolution.

New ctDNA assays could make more metastatic melanoma cases detectable.